Relationship between endothelial dysfunction and microalbuminuria in familial Mediterranean fever

Hakan Güneş1, Tarık Kıvrak1, Mustafa Tatlısu1

  • 1Clinic of Cardiology, Sivas Numune Hospital, Sivas, Turkey.

Abstract

Insights

Familial Mediterranean Fever (FMF) patients show a correlation between microalbuminuria and flow-mediated dilatation (FMD), indicating potential early markers for renal damage and endothelial dysfunction.

Area of Science:

  • Rheumatology
  • Nephrology
  • Cardiology

Background:

  • Familial Mediterranean Fever (FMF) is a genetic autoinflammatory disease characterized by recurrent inflammatory attacks.
  • Chronic low-grade inflammation in FMF can lead to systemic complications, including endothelial dysfunction and renal damage.
  • Microalbuminuria serves as an early indicator of renal damage and is associated with cardiovascular risk.

Purpose of the Study:

  • To investigate the relationship between microalbuminuria and flow-mediated dilatation (FMD) in patients with Familial Mediterranean Fever (FMF).
  • To assess endothelial function and identify potential early markers of renal damage in FMF patients.

Main Methods:

  • A study was conducted involving 54 FMF patients (out of attack period) and 40 healthy controls.
  • FMF patients were categorized based on the presence (11 patients) or absence (43 patients) of microalbuminuria.
  • Flow-mediated dilatation (FMD) was measured and compared across patient subgroups and controls.

Main Results:

  • No significant age difference was observed between FMF patients and controls.
  • Flow-mediated dilatation (FMD) percentages showed a statistically significant difference among the three groups (p=0.01).
  • A significant correlation was found between the presence of microalbuminuria and reduced FMD percentages in FMF patients.

Conclusions:

  • Endothelial dysfunction and renal damage are consequences of chronic inflammation in FMF.
  • Microalbuminuria and FMD are valuable indicators of endothelial dysfunction and early renal damage in FMF patients.
  • Monitoring FMD and microalbuminuria may aid in the early detection and management of subclinical organ damage in FMF.